We're excited to recruit for a clinical trial for a weight loss medication that is already approved for adults and is being assessed for adolescents.
The weight loss medication is Qymsia (phentermine/topiramate ER). It is a medication already FDA approved in adults for weight loss, but is seeking approval to be given in the 12-16 year old age range.
The study includes giving the above medication with a lifestyle modification program.
Patients can earn up to $1300 ($100 per visit) for compensation for time and travel.
-12 to 16 years of age
-If type 2 diabetes is present, the HbA1C must be less than the 10th percentile
-Obesity cannot be due to a known or genetic or endocrine origin, such as Prader-Willi Syndrome
-Must NOT be taking stimulants, tricyclic antidepressants, buproprion, or anticonvulsant medications
We are helping to recruit for this study only. If you are interested please call the Center for Pharmaceutical Research enrollment services at 816-943-0770.